Profile data is unavailable for this security.
About the company
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
- Revenue in USD (TTM)6.56m
- Net income in USD-14.92m
- Incorporated1997
- Employees36.00
- LocationSol Gel Technologies LtdGolda Meir 7NESS-ZIONA 7403650IsraelISR
- Phone+972 89313433
- Fax+972 89313434
- Websitehttp://www.sol-gel.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sensei Biotherapeutics Inc | 0.00 | -29.67m | 13.98m | 28.00 | -- | 0.2677 | -- | -- | -1.18 | -1.18 | 0.00 | 2.08 | 0.00 | -- | -- | 0.00 | -39.73 | -47.03 | -42.67 | -54.33 | -- | -- | -- | -- | -- | -- | 0.0232 | -- | -- | -- | 29.82 | -- | 42.16 | -- |
| Hcw Biologics Inc | 3.92m | -38.37m | 14.00m | 45.00 | -- | -- | -- | 3.57 | -1.04 | -1.04 | 0.1068 | -0.1666 | 0.1183 | -- | 5.76 | 87,170.22 | -115.73 | -- | -199.07 | -- | 31.17 | -- | -978.10 | -- | -- | -146.50 | 2.75 | -- | -57.72 | -- | -67.74 | -- | -- | -- |
| NRX Pharmaceuticals Inc | 0.00 | -24.83m | 14.14m | 2.00 | -- | -- | -- | -- | -1.62 | -1.62 | 0.00 | -1.70 | 0.00 | -- | -- | -- | -197.97 | -120.57 | -- | -168.40 | -- | -- | -- | -- | -- | -189.12 | -- | -- | -- | -- | 24.14 | -- | -- | -- |
| OpGen Inc | 1.96m | -22.39m | 14.20m | 100.00 | -- | -- | -- | 7.23 | -20.01 | -20.01 | 1.66 | -8.65 | 0.1553 | -- | 6.09 | -- | -176.99 | -87.95 | -15,455.17 | -127.65 | 3.15 | 15.42 | -1,139.66 | -794.78 | -- | -20.25 | -- | -- | 31.11 | 3.02 | 12.38 | -- | 40.20 | -- |
| Inhibitor Therapeutics Inc | 0.00 | -3.02m | 14.99m | 3.00 | -- | 3.62 | -- | -- | -0.0175 | -0.0175 | 0.00 | 0.024 | 0.00 | -- | -- | 0.00 | -34.83 | 27.48 | -34.99 | 32.70 | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | -- | -- | -125.39 | -- | -- | -- |
| AIM ImmunoTech Inc | 201.00k | -28.05m | 15.45m | 26.00 | -- | 2.28 | -- | 76.87 | -0.5703 | -0.5703 | 0.004 | 0.1068 | 0.0082 | -- | 12.18 | 7,730.77 | -113.70 | -45.64 | -149.16 | -48.35 | 71.14 | -231.75 | -13,952.74 | -11,695.01 | -- | -- | 0.3018 | -- | 43.26 | -11.26 | -48.94 | -- | 35.73 | -- |
| Sol Gel Technologies Ltd | 6.56m | -14.92m | 15.62m | 36.00 | -- | 0.4475 | -- | 2.38 | -0.5354 | -0.5354 | 0.2355 | 1.25 | 0.1351 | -- | 1.59 | 182,194.40 | -30.72 | -31.60 | -34.59 | -35.49 | -- | -- | -227.40 | -135.76 | -- | -- | 0.00 | -- | -59.98 | 64.50 | -82.52 | -- | -33.78 | -- |
| Eom Pharmaceutical Holdings Inc | 0.00 | -4.93m | 15.86m | 3.00 | -- | -- | -- | -- | -0.0435 | -0.0435 | 0.00 | -0.0212 | -- | -- | -- | 0.00 | -- | -126.34 | -- | -171.37 | -- | -- | -- | -- | -- | -- | 7.41 | -- | -- | -- | -254.37 | -- | -- | -- |
| IN8BIO, Inc. | 0.00 | -31.96m | 16.08m | 31.00 | -- | 1.17 | -- | -- | -0.8357 | -0.8357 | 0.00 | 0.2933 | 0.00 | -- | -- | 0.00 | -122.41 | -74.18 | -146.35 | -84.42 | -- | -- | -- | -- | -- | -- | 0.0945 | -- | -- | -- | -5.21 | -- | -4.54 | -- |
| Traws Pharma Inc | 226.00k | -137.05m | 16.10m | 16.00 | -- | -- | -- | 71.25 | -138.17 | -138.17 | 0.2557 | 6.03 | 0.0092 | -- | 12.91 | 14,125.00 | -557.63 | -63.43 | -896.39 | -85.72 | -- | -- | -60,641.15 | -3,257.92 | -- | -- | 0.00 | -- | 0.00 | -28.72 | 0.0844 | -- | -- | -- |
| Tenax Therapeutics Inc | 0.00 | -12.57m | 16.16m | 5.00 | -- | 1.05 | -- | -- | -22.35 | -22.35 | 0.00 | 4.53 | 0.00 | -- | -- | 0.00 | -101.95 | -199.16 | -113.79 | -285.64 | -- | -- | -- | -- | -- | -95.94 | 0.0305 | -- | -- | -- | 30.21 | -- | -- | -- |
| Minerva Neurosciences Inc | 0.00 | -3.31m | 16.39m | 9.00 | -- | -- | -- | -- | -0.4357 | -0.4357 | 0.00 | -3.10 | 0.00 | -- | -- | 0.00 | -6.25 | -49.89 | -6.75 | -52.39 | -- | -- | -- | -442.65 | -- | -- | -- | -- | -- | -- | 6.55 | -- | -- | -- |
| Geovax Labs Inc | 300.68k | -26.92m | 16.62m | 17.00 | -- | -- | -- | 55.29 | -13.05 | -13.05 | 0.1389 | -0.5526 | 0.0237 | -- | -- | 17,687.06 | -212.40 | -108.34 | -362.39 | -147.24 | -- | -- | -8,951.51 | -1,842.93 | -- | -- | -- | -- | -100.00 | -- | -85.20 | -- | -- | -- |
| Microbot Medical Inc | 0.00 | -10.44m | 16.83m | 22.00 | -- | 2.69 | -- | -- | -0.81 | -0.81 | 0.00 | 0.3793 | 0.00 | -- | -- | 0.00 | -113.94 | -53.28 | -133.34 | -62.65 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 18.44 | -- | -31.76 | -- |
| Synlogic Inc | 3.17m | -56.16m | 16.92m | 6.00 | -- | 1.06 | -- | 5.34 | -7.24 | -7.24 | 0.3549 | 1.37 | 0.0628 | -- | -- | 528,333.30 | -111.31 | -40.57 | -131.17 | -43.82 | -- | -- | -1,771.74 | -3,245.93 | -- | -- | 0.00 | -- | 185.68 | 5.99 | 13.40 | -- | -48.05 | -- |
| Kairos Pharma Ltd | 0.00 | -2.01m | 17.21m | -- | -- | -- | -- | -- | -0.1562 | -0.1562 | 0.00 | -0.2067 | 0.00 | -- | -- | -- | -199.80 | -- | -- | -- | -- | -- | -- | -- | -- | -15.58 | -- | -- | -- | -- | -72.57 | -- | -- | -- |
Data as of Nov 08 2024. Currency figures normalised to Sol Gel Technologies Ltd's reporting currency: US Dollar USD
26.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Phoenix Investments House Ltd.as of 30 Sep 2024 | 2.47m | 8.87% |
| Armistice Capital LLCas of 30 Jun 2024 | 2.03m | 7.29% |
| Migdal Insurance Co. Ltd. (Investment Portfolio)as of 30 Sep 2024 | 1.23m | 4.41% |
| Harel Mutual Funds Ltd.as of 30 Sep 2024 | 920.33k | 3.30% |
| Yelin Lapidot Mutual Fund Management Ltd.as of 30 Sep 2024 | 229.18k | 0.82% |
| Kingdon Capital Management LLCas of 30 Jun 2024 | 121.71k | 0.44% |
| Raymond James Financial Services Advisors, Inc.as of 30 Sep 2024 | 88.46k | 0.32% |
| Menora Mivtachim Insurance Ltd.as of 30 Jun 2024 | 76.11k | 0.27% |
| Morgan Stanley & Co. LLCas of 30 Jun 2024 | 65.46k | 0.24% |
| Raymond James & Associates, Inc. (Invt Mgmt)as of 30 Sep 2024 | 31.62k | 0.11% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
